ASHLEY WILSON: Open Payments
NPI 1487655106 · LITTLE RIVER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 40 payments from 18 companies in 2025. Trend: 2023 $1,477 · 2024 $600 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 5 | $156 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| Amgen Inc. | 5 | $76 |
| Novo Nordisk Inc | 2 | $44 |
| ABBVIE INC. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Corcept Therapeutics | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| Exact Sciences Corporation | 2 | $34 |
Products named: TARPEYO, AIRSUPRA, OTEZLA, Ozempic, VRAYLAR, CAPLYTA, Korlym, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
